Exact Mass: 434.1665

Exact Mass Matches: 434.1665

Found 43 metabolites which its exact mass value is equals to given mass value 434.1665, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Fluvoxamine maleate

Fluvoxamine maleate

C19H25F3N2O6 (434.1665)


   

Cys Cys Ile Pro

(2S)-1-[(2S,3S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C17H30N4O5S2 (434.1658)


   

Cys Cys Leu Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C17H30N4O5S2 (434.1658)


   

Cys Cys Pro Ile

(2S,3S)-2-{[(2S)-1-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C17H30N4O5S2 (434.1658)


   

Cys Cys Pro Leu

(2S)-2-{[(2S)-1-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C17H30N4O5S2 (434.1658)


   

Cys Ile Cys Pro

(2S)-1-[(2R)-2-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C17H30N4O5S2 (434.1658)


   

Cys Ile Pro Cys

(2R)-2-{[(2S)-1-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C17H30N4O5S2 (434.1658)


   

Cys Leu Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-methylpentanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C17H30N4O5S2 (434.1658)


   

Cys Leu Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C17H30N4O5S2 (434.1658)


   

Cys Pro Cys Ile

(2S,3S)-2-[(2R)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-methylpentanoic acid

C17H30N4O5S2 (434.1658)


   

Cys Pro Cys Leu

(2S)-2-[(2R)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-4-methylpentanoic acid

C17H30N4O5S2 (434.1658)


   

Cys Pro Ile Cys

(2R)-2-[(2S,3S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-sulfanylpropanoic acid

C17H30N4O5S2 (434.1658)


   

Cys Pro Leu Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-sulfanylpropanoic acid

C17H30N4O5S2 (434.1658)


   

Gly Met Met Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C17H30N4O5S2 (434.1658)


   

Gly Met Pro Met

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C17H30N4O5S2 (434.1658)


   

Gly Pro Met Met

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid

C17H30N4O5S2 (434.1658)


   

Ile Cys Cys Pro

(2S)-1-[(2R)-2-[(2R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C17H30N4O5S2 (434.1658)


   

Ile Cys Pro Cys

(2R)-2-{[(2S)-1-[(2R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C17H30N4O5S2 (434.1658)


   

Ile Pro Cys Cys

(2R)-2-[(2R)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H30N4O5S2 (434.1658)


   

Leu Cys Cys Pro

(2S)-1-[(2R)-2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C17H30N4O5S2 (434.1658)


   

Leu Cys Pro Cys

(2R)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C17H30N4O5S2 (434.1658)


   

Leu Pro Cys Cys

(2R)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H30N4O5S2 (434.1658)


   

Met Gly Met Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C17H30N4O5S2 (434.1658)


   

Met Gly Pro Met

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetyl}pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C17H30N4O5S2 (434.1658)


   

Met Met Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]acetyl}pyrrolidine-2-carboxylic acid

C17H30N4O5S2 (434.1658)


   

Met Met Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}acetic acid

C17H30N4O5S2 (434.1658)


   

Met Pro Gly Met

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}acetamido)-4-(methylsulfanyl)butanoic acid

C17H30N4O5S2 (434.1658)


   

Met Pro Met Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]acetic acid

C17H30N4O5S2 (434.1658)


   

Pro Cys Cys Ile

(2S,3S)-3-methyl-2-[(2R)-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]pentanoic acid

C17H30N4O5S2 (434.1658)


   

Pro Cys Cys Leu

(2S)-4-methyl-2-[(2R)-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]pentanoic acid

C17H30N4O5S2 (434.1658)


   

Pro Cys Ile Cys

(2R)-2-[(2S,3S)-3-methyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]pentanamido]-3-sulfanylpropanoic acid

C17H30N4O5S2 (434.1658)


   

Pro Cys Leu Cys

(2R)-2-[(2S)-4-methyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]pentanamido]-3-sulfanylpropanoic acid

C17H30N4O5S2 (434.1658)


   

Pro Gly Met Met

(2S)-4-(methylsulfanyl)-2-[(2S)-4-(methylsulfanyl)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]butanoic acid

C17H30N4O5S2 (434.1658)


   

Pro Ile Cys Cys

(2R)-2-[(2R)-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H30N4O5S2 (434.1658)


   

Pro Leu Cys Cys

(2R)-2-[(2R)-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H30N4O5S2 (434.1658)


   

Pro Met Gly Met

(2S)-4-(methylsulfanyl)-2-{2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}butanoic acid

C17H30N4O5S2 (434.1658)


   

Pro Met Met Gly

2-[(2S)-4-(methylsulfanyl)-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]acetic acid

C17H30N4O5S2 (434.1658)


   

[(1R,5R)-3-(bromomethylidene)-5-[tert-butyl(dimethyl)silyl]oxycyclohexyl]oxy-tert-butyl-dimethylsilane

[(1R,5R)-3-(bromomethylidene)-5-[tert-butyl(dimethyl)silyl]oxycyclohexyl]oxy-tert-butyl-dimethylsilane

C19H39BrO2Si2 (434.1672)


   

Fluvoxamine maleat

(E)-But-2-enedioic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine

C19H25F3N2O6 (434.1665)


D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065689 - Cytochrome P-450 CYP2C19 Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors D049990 - Membrane Transport Modulators C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

(1S,5R)-7-[4-(2-methoxyphenyl)phenyl]-3-(4-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane

(1S,5R)-7-[4-(2-methoxyphenyl)phenyl]-3-(4-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane

C25H26N2O3S (434.1664)


   

(1S,5R)-7-[4-(3-methoxyphenyl)phenyl]-3-(phenylmethyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane

(1S,5R)-7-[4-(3-methoxyphenyl)phenyl]-3-(phenylmethyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane

C25H26N2O3S (434.1664)


   

(1S,5R)-7-[4-(4-methoxyphenyl)phenyl]-3-(2-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane

(1S,5R)-7-[4-(4-methoxyphenyl)phenyl]-3-(2-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane

C25H26N2O3S (434.1664)


   

(1S,5R)-3-(2-methoxyphenyl)sulfonyl-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane

(1S,5R)-3-(2-methoxyphenyl)sulfonyl-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane

C25H26N2O3S (434.1664)